New drug study aims to tame uncontrolled seizures
NCT ID NCT05859854
Summary
This study is observing how well the drug cenobamate works for adults with focal epilepsy whose seizures are not controlled by at least two other medications. It follows 936 patients in Italy for one year to see how much it reduces seizure frequency and to check for side effects. The goal is to gather real-world information on the drug's effectiveness and safety when used in regular clinical practice.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Associazione La Nostra Famiglia - IRCCS Eugenio Medea
Conegliano, Treviso, 31015, Italy
-
Azienda Sanitaria Universitaria (A.O.U.) Integrata
Udine, Udine, 33100, Italy
-
Campus Bio-Medico
Roma, Roma, 00128, Italy
-
Fondazione Istituto Neurologico Casimiro Mondino
Pavia, Pavia, 27100, Italy
-
Humanitas Gradenigo
Torino, Torino, 10153, Italy
-
IRCCS Neuromed
Pozzilli, Isernia, 86077, Italy
-
Ospedale San Bortolo
Vicenza, Vicenza, 36100, Italy
-
Policlinico Umberto I
Roma, Roma, 00161, Italy
-
Policlinico di Bari
Bari, Bari, 70124, Italy
-
Università degli Studi di Catanzaro "Magna Graecia"
Catanzaro, Catanzaro, 88100, Italy
Conditions
Explore the condition pages connected to this study.